Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by kevinNashon Dec 11, 2018 12:08pm
86 Views
Post# 29097532

RE:only thing endell can say is working on it

RE:only thing endell can say is working on it
edrose wrote: like pl as been saying for more than two years working on deals
he's trying to find co. who will give him money letting him make 100 % of decisions good luck with that


38 cents a share.  It's pathetic.  The only way to end this is to come up with something substantial.  Management has had all year to make a deal and where is it?  They've obviously completely lost trust of investors.  It's reflected in the ridiculous volumes all year in this.  Stop being a clown PL. For once put investors first over your ego and announce a finalized deal.   And what's the status of that "fast track" again?
Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse